Biotech startup Numab Therapeutics specialising in proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology has entered a research and option agreement with Ono Pharmaceutical Co., Ltd. for the identification of a multi-specific antibody candidate for development in immuno-oncology. Numab will receive up to CHF 258 million plus tiered royalties on sales.
ShapeShift is the world’s leading instant exchange for Bitcoin digital currency and other blockchain assets with an exchange volume of more than 50,000 Bitcoins (CHF50 million) per Month. The Zug-based start-up today announced the completion of its $10.4 million Series A funding round led by Earlybird and joined by Lakestar.
The funding round for the biotech start-up was led by Redalpine Venture Partners. The funding brings resources to advance Versantis’ lead candidate VS-01 to first-in-human study and transform the care of patients with rare and life-threatening liver diseases.
Swiss Startup Invest has completely redesigned its Swiss Venture Day to allow for more meetings, keynote speeches and startup pitches. 22 startups have been selected to pitch at the first reloaded event on 5. April 2017. Registration to attend the event is open until 1. April.
ESA BIC operates a technology transfer programme offering targeted support and funding to start-ups in the field of space technologies and applications. Last week seven start-ups were selected for the program.